Jump to content

Mary Ann Liebert

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Aetkin (talk | contribs) at 14:56, 13 October 2006. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Founded in 1980, Mary Ann Liebert, Inc. is universally acknowledged for publishing authoritative peer-reviewed journals, books, and trade magazines in the most promising areas of biotechnology, biomedical research/life sciences, clinical medicine and surgery, and law.

MAL publishes Genetic Engineering News, the very first trade publication in biotechnology, and the most widely-read biotechnology trade publication worldwide. The first to publish a medical journal on AIDS, long before this disease was designated as a serious threat to world health. Another Liebert journal that is first in its field is Human Gene Therapy, the leading journal on this subject matter. Journal of Women's Health recognized and supported the importance of gender-based medicine, which benefits both men and women, and Alternative & Complementary Therapies provides health care professionals with the information they need to evaluate unconventional therapies and their place in patient care. Biosecurity and Bioterrorism is an example of meeting an urgent need at a critical time.

These publications not only contribute significantly to the literature but play an active and important role in the advancement of their respective fields. MAL actively seeks out areas of embryonic endeavor and nurture them with the care and perseverance that only an independent, privately-owned company can provide.

Copyright (c) 2006 Mary Ann Liebert, Inc. Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1.2 or any later version published by the Free Software Foundation; with no Invariant Sections, no Front-Cover Texts, and no Back-Cover Texts. A copy of the license is included in the section entitled "GNU Free Documentation License".